Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0720-0032
ICR Reference No:
201606-0720-001
Status:
Historical Active
Previous ICR Reference No:
201301-0720-001
Agency/Subagency:
DOD/DODOASHA
Agency Tracking No:
Title:
Federal Agency Retail Pharmacy Program
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
08/05/2016
Retrieve Notice of Action (NOA)
Date Received in OIRA:
06/06/2016
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
08/31/2019
36 Months From Approved
08/31/2016
Responses
1,200
0
2,000
Time Burden (Hours)
9,600
0
16,000
Cost Burden (Dollars)
403,968
0
0
Abstract:
DoD is extending information collections requirements under current OMB Control Number 0720-0032. Pharmaceutical manufacturers will base refund calculation on difference between average non-Federal price of drug sold by pharmaceutical manufacturer to wholesalers, represented by most recent annual non-Federal average manufacturing prices (non-FAMP) and corresponding Federal Ceiling Price (FCP) or, at discretion of pharmaceutical manufacturer, difference between FCP and direct commercial contract sales price attributable to applicable National Drug Code.
Authorizing Statute(s):
US Code:
10 USC 1074g(f)
Name of Law: Pharmacy benefits program
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
80 FR 68301
11/04/2015
30-day Notice:
Federal Register Citation:
Citation Date:
81 FR 36282
06/06/2016
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
1
IC Title
Form No.
Form Name
Federal Agency Retail Pharmacy Program
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
1,200
2,000
0
-800
0
0
Annual Time Burden (Hours)
9,600
16,000
0
-6,400
0
0
Annual Cost Burden (Dollars)
403,968
0
0
403,968
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Cutting Redundancy
Short Statement:
There has been an increase in the number of pharmaceutical manufacturers who have covered drugs eligible for the TRRP. Based upon analysis of the utilization data used in prior billings, DHA determined it needed to re-bill the 3rd Quarter Calendar Year (QCY) 2009 to 4th QCY 2011 utilization data during the last OMB renewal period. DHA does not anticipate that re-billing additional quarters will be necessary. As a result, this reduces the number of responses per respondent from 8 to 4 annually.
Annual Cost to Federal Government:
$4,361,120
Does this IC contain surveys, censuses, or employ statistical methods?
No
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Caitlyn Borghi 571 372-0492 caitlyn.a.borghi.ctr@mail.mil
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
06/06/2016